Streptococcal pneumonia
MONDO:0005972A febrile disease caused by streptococcus pneumoniae.
Also known as: Streptococcus pneumoniae caused pneumonia, Streptococcus pneumoniae pneumonia, pneumococcal pneumonia, pneumonia due to streptococcus, streptococcal pneumonia, Streptococcus pneumonia, pneumonia caused by streptococcus
70 clinical trials for this condition and its sub-types, 16 tagged with Streptococcal pneumonia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New vaccine strategy could shield lymphoma survivors from pneumonia
Vaccine OngoingThis study looks at how well a pneumonia vaccine (PCV20) works in people who have recovered from B-cell lymphoma and were treated with anti-CD20 therapy. Researchers want to see if a single dose or a boosted dose is safer and more effective at preventing pneumococcal infections. …
Phase 4 • Sponsor: M.D. Anderson Cancer Center • Aim: Vaccine
Last updated Sep 17, 2026 00:00 UTC
-
New pneumonia vaccine trial aims to protect adults safely
Vaccine OngoingThis study tests a new pneumococcal vaccine (PG4) to see if it is safe and tolerable in adults. About 380 healthy adults will receive either the experimental vaccine, a similar vaccine, a standard vaccine, or a placebo. Participants will be monitored for side effects and give blo…
Phase 1 • Sponsor: Pfizer • Aim: Vaccine
Last updated Jun 27, 2026 14:01 UTC
-
Massive study of 22 million seniors tests pneumonia Vaccine's Real-World power
Vaccine OngoingThis study looks at how effective the Prevnar 20 (PCV20) vaccine is at preventing serious lung infections in people aged 65 and older. Researchers will analyze medical records from over 22 million Medicare beneficiaries, comparing those who got the vaccine to those who did not. T…
Sponsor: Pfizer • Aim: Vaccine
Last updated Jun 27, 2026 12:23 UTC
-
CAR-T vaccine study pulled before it began
Knowledge-focused CancelledThis study was designed to track how the immune system recovers after CAR-T cell therapy and to test a pneumococcal vaccine (PCV-21) in these patients. It planned to enroll 50 adults with blood cancers or solid tumors. However, the study was withdrawn before any participants were…
Phase 1/2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC